Empagliflozin vs Lisinopril
Empagliflozin vs Lisinopril: Overview
This comparison examines the pharmacological differences between Empagliflozin and Lisinopril.
Mechanism of Action
Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.
Lisinopril: ACE inhibitor preventing conversion of angiotensin I to angiotensin II.
Pharmacokinetics
Half-life: Empagliflozin β 12.4 hours; Lisinopril β 12 hours.
Chemical Properties
Molecular Formula: Empagliflozin β C23H27ClO7; Lisinopril β C21H31N3O5.
Molecular Weight: Empagliflozin β 450.9100 g/mol; Lisinopril β 405.4900 g/mol.
Type: Empagliflozin β Small molecule; Lisinopril β Small molecule.